Tivic Health Systems, Inc. (TIVC)
USD 4.87
(49.85%)
USD 4.87
(49.85%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 8.53 Million USD | -18.01% |
| 2022 | 10.39 Million USD | 88.93% |
| 2021 | 5.5 Million USD | 84.73% |
| 2020 | 2.97 Million USD | -11.18% |
| 2019 | 3.35 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 1.64 Million USD | -26.66% |
| 2024 Q2 | 1.23 Million USD | -25.0% |
| 2023 Q2 | 2.18 Million USD | -1.93% |
| 2023 Q1 | 2.22 Million USD | -3.04% |
| 2023 FY | 8.52 Million USD | -18.01% |
| 2023 Q4 | 2.24 Million USD | 20.29% |
| 2023 Q3 | 1.86 Million USD | -14.55% |
| 2022 Q4 | 2.29 Million USD | -13.15% |
| 2022 Q2 | 3.14 Million USD | 36.0% |
| 2022 Q1 | 2.31 Million USD | 1.99% |
| 2022 FY | 10.39 Million USD | 88.93% |
| 2022 Q3 | 2.64 Million USD | -15.78% |
| 2021 Q3 | 1.2 Million USD | 17.71% |
| 2021 Q4 | 2.26 Million USD | 88.36% |
| 2021 Q2 | 1.02 Million USD | -5.28% |
| 2021 FY | 5.5 Million USD | 84.73% |
| 2021 Q1 | 1.07 Million USD | 49.24% |
| 2020 Q3 | 758 Thousand USD | 46.62% |
| 2020 FY | 2.97 Million USD | -11.18% |
| 2020 Q4 | 723 Thousand USD | -4.62% |
| 2020 Q2 | 516.99 Thousand USD | -46.59% |
| 2020 Q1 | 968 Thousand USD | 0.0% |
| 2019 FY | 3.35 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | 23.984% |
| Cerus Corporation | 143.15 Million USD | 94.04% |
| OrthoPediatrics Corp. | 137.01 Million USD | 93.773% |
| PetVivo Holdings, Inc. | 11.36 Million USD | 24.9% |
| Talis Biomedical Corporation | 67.18 Million USD | 87.301% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | 65.798% |
| Inogen, Inc. | 236.08 Million USD | 96.386% |
| Spectral AI, Inc. | 20.86 Million USD | 59.107% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 84.763% |
| CVRx, Inc. | 76.14 Million USD | 88.795% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -141.837% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | 31.684% |
| Orthofix Medical Inc. | 667.42 Million USD | 98.722% |
| Venus Concept Inc. | 80.47 Million USD | 89.398% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 84.92% |
| Bioventus Inc. | 409.91 Million USD | 97.919% |
| BrainsWay Ltd. | 28.01 Million USD | 69.548% |
| Envoy Medical, Inc. | 17.89 Million USD | 52.33% |
| electroCore, Inc. | 32.03 Million USD | 73.363% |
| IceCure Medical Ltd | 16.87 Million USD | 49.443% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 79.893% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | 51.614% |
| MaxCyte, Inc. | 84.84 Million USD | 89.944% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | 31.259% |
| Nexalin Technology, Inc. | 5.78 Million USD | -47.578% |
| PAVmed Inc | 64.82 Million USD | 86.839% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 83.296% |
| RxSight, Inc. | 103.85 Million USD | 91.784% |
| Sight Sciences, Inc. | 126.44 Million USD | 93.253% |
| SI-BONE, Inc. | 156.35 Million USD | 94.543% |
| TELA Bio, Inc. | 84.18 Million USD | 89.865% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 87.821% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 95.805% |
| LivaNova PLC | 843.54 Million USD | 98.989% |
| 908 Devices Inc. | 68.08 Million USD | 87.468% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 98.236% |
| Nemaura Medical Inc. | 7.13 Million USD | -19.516% |
| NeuroPace, Inc. | 75.29 Million USD | 88.669% |
| LENSAR, Inc. | 33.33 Million USD | 74.406% |
| Apyx Medical Corporation | 51.01 Million USD | 83.276% |
| Cutera, Inc. | 197.72 Million USD | 95.685% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | 65.57% |
| BioSig Technologies, Inc. | 28.53 Million USD | 70.095% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 95.544% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 76.339% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 98.98% |
| Axonics, Inc. | 270.2 Million USD | 96.842% |
| Outset Medical, Inc. | 198.77 Million USD | 95.708% |
| IRIDEX Corporation | 31.81 Million USD | 73.182% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 95.266% |
| IRadimed Corporation | 30.12 Million USD | 71.676% |
| INVO Bioscience, Inc. | 7.85 Million USD | -8.642% |
| Telesis Bio, Inc. | 63.48 Million USD | 86.561% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 91.334% |
| Varex Imaging Corporation | 224.8 Million USD | 96.205% |
| Quipt Home Medical Corp. | 148.66 Million USD | 94.261% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | 27.22% |
| Pulmonx Corporation | 112.68 Million USD | 92.429% |
| Dynatronics Corporation | 9.9 Million USD | 13.888% |
| Modular Medical, Inc. | 17.52 Million USD | 51.326% |
| ReShape Lifesciences Inc. | 20.18 Million USD | 57.735% |
| Semler Scientific, Inc. | 38.94 Million USD | 78.092% |
| InMode Ltd. | 215.68 Million USD | 96.044% |
| Bruker Corporation | 1.07 Billion USD | 99.207% |
| Cytosorbents Corporation | 48.33 Million USD | 82.349% |
| DexCom, Inc. | 1.69 Billion USD | 99.496% |
| Align Technology, Inc. | 2.07 Billion USD | 99.589% |
| Viveve Medical, Inc. | 22.17 Million USD | 61.521% |
| ZimVie Inc. | 275.12 Million USD | 96.899% |
| Movano Inc. | 29.69 Million USD | 71.263% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 93.785% |
| Nexalin Technology, Inc. | 5.78 Million USD | -47.578% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -141.837% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 98.58% |
| Profound Medical Corp. | 33.6 Million USD | 74.61% |
| Insulet Corporation | 939.9 Million USD | 99.092% |
| enVVeno Medical Corporation | 25.23 Million USD | 66.194% |
| Surmodics, Inc. | 98.69 Million USD | 91.355% |
| iCAD, Inc. | 22.22 Million USD | 61.611% |
| Nuwellis, Inc. | 22.61 Million USD | 62.269% |
| Biotricity, Inc. | 17.18 Million USD | 50.351% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 98.087% |
| Aethlon Medical, Inc. | 12.27 Million USD | 30.507% |
| InspireMD, Inc. | 22.95 Million USD | 62.824% |
| PAVmed Inc. | 64.82 Million USD | 86.839% |
| BIOLASE, Inc. | 34.66 Million USD | 75.384% |
| Beyond Air, Inc. | 61.7 Million USD | 86.172% |
| FONAR Corporation | 28.6 Million USD | 70.173% |
| AxoGen, Inc. | 149.33 Million USD | 94.287% |
| Vivani Medical, Inc. | 26.96 Million USD | 68.359% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 95.182% |
| Inari Medical, Inc. | 448.59 Million USD | 98.098% |
| UFP Technologies, Inc. | 58.08 Million USD | 85.312% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -73.147% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -35.037% |
| Tenon Medical, Inc. | 16.96 Million USD | 49.717% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -15.406% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 80.654% |
| AdaptHealth Corp. | 1.07 Billion USD | 99.209% |
| Sintx Technologies, Inc. | 15.2 Million USD | 43.872% |
| NanoVibronix, Inc. | 4.97 Million USD | -71.566% |
| Quanterix Corporation | 118.1 Million USD | 92.776% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | 27.22% |
| Sensus Healthcare, Inc. | 14.44 Million USD | 40.922% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 97.827% |
| TransMedics Group, Inc. | 182.82 Million USD | 95.333% |
| ReWalk Robotics Ltd. | 28.06 Million USD | 69.599% |
| NeuroMetrix, Inc. | 11.09 Million USD | 23.128% |
| Hyperfine, Inc. | 52.87 Million USD | 83.863% |
| Establishment Labs Holdings Inc. | 172 Million USD | 95.04% |
| Biomerica, Inc. | 6.97 Million USD | -22.27% |
| Bone Biologics Corporation | 9.42 Million USD | 9.507% |
| AVITA Medical, Inc. | 80.77 Million USD | 89.438% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | 17.255% |
| Silk Road Medical, Inc | 186.35 Million USD | 95.422% |